Document Detail

Urocortin in pregnancy.
MedLine Citation:
PMID:  9731865     Owner:  NLM     Status:  MEDLINE    
OBJECTIVES: The aim of this study was to investigate the possibility that urocortin is the ligand that displaces corticotropin-releasing hormone from its binding protein in the maternal circulation during pregnancy and, if so, to determine whether urocortin, like corticotropin-releasing hormone, is synthesized in substantial quantities in the placenta. STUDY DESIGN: A radioimmunoassay specific for urocortin was developed and used for measurement of the peptide in chorionic villi and fetal membranes (amnion and chorion) from normal and preeclamptic pregnancies. These tissues were also assayed for corticotropin-releasing hormone. Assays for urocortin were also carried out on normal term pregnant and nonpregnant myometrium and on plasma from nonpregnant individuals, and assays for both peptides were performed on sequential normal pregnancy plasma samples taken from mid gestation until term. RESULTS: Corticotropin-releasing hormone was present in normal term (1904 +/- 489 pg/g) and preeclamptic placentas (5897 +/- 1526 pg/g) and in normal term fetal membranes (645 +/- 155 pg/g, n = 6 in all cases). Urocortin was not detected in any of the tissues studied, nor was it found in the normal human plasma samples. Unlike the situation for corticotropin-releasing hormone, no pregnancy-related pattern was seen for urocortin in the plasma from pregnant women. CONCLUSIONS: Urocortin is not translated to any great extent in the pregnancy tissues investigated, nor is it present in the circulation of pregnant women in detectable amounts. Furthermore, it is unlikely that urocortin is responsible for the high maternal plasma levels of free corticotropin-releasing hormone circulating in the latter stages of pregnancy, but this does not preclude the possibility that another, as yet uncharacterized, corticotropin-releasing hormone-like peptide may be.
B P Glynn; A Wolton; B Rodríguez-Liñares; S Phaneuf; E A Linton
Related Documents :
7459285 - Serial changes in renal haemodynamics during normal human pregnancy.
10736245 - Detection of n-terminal pro-corticotrophin releasing hormone (crh) and a 'novel' crh in...
10761825 - Healthy outcome under olanzapine treatment in a pregnant woman.
7633195 - Fibronectin levels in normal pregnancy and preeclampsia.
8943545 - The roles of oligomenorrhoea and fetal chromosomal abnormalities in spontaneous abortions.
11125665 - Momma. multi-centered on-going mothers monitoring algorithm for perinatal behavioral he...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  American journal of obstetrics and gynecology     Volume:  179     ISSN:  0002-9378     ISO Abbreviation:  Am. J. Obstet. Gynecol.     Publication Date:  1998 Aug 
Date Detail:
Created Date:  1998-09-17     Completed Date:  1998-09-17     Revised Date:  2010-08-25    
Medline Journal Info:
Nlm Unique ID:  0370476     Medline TA:  Am J Obstet Gynecol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  533-9     Citation Subset:  AIM; IM    
Nuffield Department of Obstetrics and Gynaecology, University of Oxford, Women's Centre, John Radcliffe Hospital, United Kingdom.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Chromatography, High Pressure Liquid
Corticotropin-Releasing Hormone / analysis*,  blood,  metabolism
Pregnancy / metabolism*
Rats, Sprague-Dawley
Sensitivity and Specificity
Grant Support
//Wellcome Trust
Reg. No./Substance:
0/Urocortins; 9015-71-8/Corticotropin-Releasing Hormone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Prevention of herpes simplex virus infection and latency by prophylactic treatment with acyclovir in...
Next Document:  Doppler flow velocity waveforms of the umbilical arteries correlate with intravillous blood volume.